流行性腦脊髓膜炎疫苗(Meningococcal Vaccine)

The vaccine currently in use is a Meningococcal Polysaccharides, Immunity after one vaccination lasts for three years. (MENINGOCOCCAL POLYSACCHARIDE VACCINE A+C).

MenACWY vaccine. The MenACWY vaccine offers protection against 4 types of bacteria that can cause meningitis: meningococcal groups A, C, W and Y. The vaccine is ...

Meningococcal Meningitis · 1.At present, only one of meningococcal vaccines is specially imported for use in Taiwan –Meningococcal conjugate vaccine (MCV4, ...

2023年11月20日 — Trumenba: Vaccine providers give a 2-dose series to people 16 through 23 years old who are not at increased risk of meningococcal disease.

2023年11月1日 — Meningococcal vaccine. Information about meningococcal vaccines, who they are recommended for, how and where to get vaccinated.

Immunity following meningococcal infection is sero-group-specific. Current internationally marketed meningococcal vaccines are based either on combinations of ...

The meningococcal conjugate vaccine (MenACWY) protects against four types of meningococcal bacteria (types A, C, W, and Y). · The meningococcal B vaccine (MenB) ...

流行性腦脊髓膜炎(Meningococcal disease)，由腦膜炎球菌(Neisseria meningitidis)感染引起的. 細菌性腦膜炎或菌血症。引起人類疾病的腦膜炎雙球菌，可分為A、B、C、Y、W- ...